nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HTR2B—cardial valve—systemic scleroderma	0.0547	0.213	CbGeAlD
Mianserin—CYP1A2—Pentoxifylline—systemic scleroderma	0.0523	0.32	CbGbCtD
Mianserin—CYP1A2—Leflunomide—systemic scleroderma	0.0499	0.305	CbGbCtD
Mianserin—CYP2D6—Captopril—systemic scleroderma	0.0322	0.197	CbGbCtD
Mianserin—HTR7—myenteric nerve plexus—systemic scleroderma	0.0268	0.104	CbGeAlD
Mianserin—HTR7—pulmonary artery—systemic scleroderma	0.0189	0.0737	CbGeAlD
Mianserin—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0167	0.0649	CbGeAlD
Mianserin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0161	0.0987	CbGbCtD
Mianserin—CYP3A4—Prednisone—systemic scleroderma	0.0129	0.0789	CbGbCtD
Mianserin—HTR2A—pulmonary artery—systemic scleroderma	0.0118	0.046	CbGeAlD
Mianserin—HTR1D—artery—systemic scleroderma	0.00882	0.0343	CbGeAlD
Mianserin—HTR7—artery—systemic scleroderma	0.00702	0.0273	CbGeAlD
Mianserin—HTR1D—blood vessel—systemic scleroderma	0.00687	0.0267	CbGeAlD
Mianserin—HTR7—endothelium—systemic scleroderma	0.00593	0.0231	CbGeAlD
Mianserin—HTR7—blood vessel—systemic scleroderma	0.00547	0.0213	CbGeAlD
Mianserin—HRH2—skin of body—systemic scleroderma	0.00498	0.0194	CbGeAlD
Mianserin—HTR2A—artery—systemic scleroderma	0.00438	0.017	CbGeAlD
Mianserin—HRH2—digestive system—systemic scleroderma	0.00399	0.0155	CbGeAlD
Mianserin—HTR2A—endothelium—systemic scleroderma	0.0037	0.0144	CbGeAlD
Mianserin—HTR1D—connective tissue—systemic scleroderma	0.00352	0.0137	CbGeAlD
Mianserin—HTR2A—blood vessel—systemic scleroderma	0.00341	0.0133	CbGeAlD
Mianserin—HRH2—lung—systemic scleroderma	0.00333	0.013	CbGeAlD
Mianserin—HTR2B—smooth muscle tissue—systemic scleroderma	0.003	0.0117	CbGeAlD
Mianserin—HTR2B—skin of body—systemic scleroderma	0.00296	0.0115	CbGeAlD
Mianserin—HTR7—connective tissue—systemic scleroderma	0.00281	0.0109	CbGeAlD
Mianserin—HTR7—smooth muscle tissue—systemic scleroderma	0.00257	0.00999	CbGeAlD
Mianserin—SLC6A4—digestive system—systemic scleroderma	0.00239	0.00929	CbGeAlD
Mianserin—HTR2B—digestive system—systemic scleroderma	0.00237	0.00921	CbGeAlD
Mianserin—HTR2B—tendon—systemic scleroderma	0.00225	0.00876	CbGeAlD
Mianserin—SLC6A3—lung—systemic scleroderma	0.00218	0.00847	CbGeAlD
Mianserin—HRH1—connective tissue—systemic scleroderma	0.00209	0.00815	CbGeAlD
Mianserin—ADRA2A—connective tissue—systemic scleroderma	0.00206	0.00801	CbGeAlD
Mianserin—HTR7—digestive system—systemic scleroderma	0.00203	0.00789	CbGeAlD
Mianserin—SLC6A4—lung—systemic scleroderma	0.00199	0.00776	CbGeAlD
Mianserin—HTR2B—lung—systemic scleroderma	0.00198	0.00769	CbGeAlD
Mianserin—CYP2B6—skin of body—systemic scleroderma	0.00194	0.00754	CbGeAlD
Mianserin—HTR7—tendon—systemic scleroderma	0.00193	0.0075	CbGeAlD
Mianserin—HRH1—smooth muscle tissue—systemic scleroderma	0.00192	0.00746	CbGeAlD
Mianserin—ADRA2C—tendon—systemic scleroderma	0.00177	0.0069	CbGeAlD
Mianserin—SLC6A2—lung—systemic scleroderma	0.00176	0.00683	CbGeAlD
Mianserin—HTR2A—connective tissue—systemic scleroderma	0.00175	0.00681	CbGeAlD
Mianserin—HTR7—lung—systemic scleroderma	0.00169	0.00659	CbGeAlD
Mianserin—CYP1A2—digestive system—systemic scleroderma	0.00162	0.00629	CbGeAlD
Mianserin—HTR2A—smooth muscle tissue—systemic scleroderma	0.0016	0.00623	CbGeAlD
Mianserin—DRD2—lung—systemic scleroderma	0.0016	0.00623	CbGeAlD
Mianserin—Hypotension—Captopril—systemic scleroderma	0.00156	0.00269	CcSEcCtD
Mianserin—Pruritus—Pentoxifylline—systemic scleroderma	0.00156	0.00268	CcSEcCtD
Mianserin—Anaemia—Leflunomide—systemic scleroderma	0.00156	0.00268	CcSEcCtD
Mianserin—ADRA2C—lung—systemic scleroderma	0.00156	0.00605	CbGeAlD
Mianserin—CYP2B6—digestive system—systemic scleroderma	0.00155	0.00603	CbGeAlD
Mianserin—Tinnitus—Lisinopril—systemic scleroderma	0.00155	0.00267	CcSEcCtD
Mianserin—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00265	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00152	0.00262	CcSEcCtD
Mianserin—Arthralgia—Azathioprine—systemic scleroderma	0.00152	0.00262	CcSEcCtD
Mianserin—Myalgia—Azathioprine—systemic scleroderma	0.00152	0.00262	CcSEcCtD
Mianserin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00261	CcSEcCtD
Mianserin—HRH1—digestive system—systemic scleroderma	0.00151	0.00589	CbGeAlD
Mianserin—Vertigo—Leflunomide—systemic scleroderma	0.00151	0.00261	CcSEcCtD
Mianserin—Angiopathy—Lisinopril—systemic scleroderma	0.00151	0.0026	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00151	0.0026	CcSEcCtD
Mianserin—Leukopenia—Leflunomide—systemic scleroderma	0.00151	0.0026	CcSEcCtD
Mianserin—Tremor—Mycophenolic acid—systemic scleroderma	0.0015	0.0026	CcSEcCtD
Mianserin—Mediastinal disorder—Lisinopril—systemic scleroderma	0.0015	0.00258	CcSEcCtD
Mianserin—Paraesthesia—Captopril—systemic scleroderma	0.0015	0.00258	CcSEcCtD
Mianserin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00148	0.00256	CcSEcCtD
Mianserin—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00256	CcSEcCtD
Mianserin—Somnolence—Captopril—systemic scleroderma	0.00148	0.00256	CcSEcCtD
Mianserin—Agitation—Mycophenolic acid—systemic scleroderma	0.00148	0.00255	CcSEcCtD
Mianserin—Gynaecomastia—Methotrexate—systemic scleroderma	0.00147	0.00253	CcSEcCtD
Mianserin—Cardiac failure—Prednisone—systemic scleroderma	0.00146	0.00252	CcSEcCtD
Mianserin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00251	CcSEcCtD
Mianserin—Mental disorder—Lisinopril—systemic scleroderma	0.00146	0.00251	CcSEcCtD
Mianserin—Lethargy—Prednisone—systemic scleroderma	0.00146	0.00251	CcSEcCtD
Mianserin—Dizziness—Pentoxifylline—systemic scleroderma	0.00145	0.00251	CcSEcCtD
Mianserin—Hypertension—Leflunomide—systemic scleroderma	0.00145	0.00251	CcSEcCtD
Mianserin—Vertigo—Mycophenolic acid—systemic scleroderma	0.00144	0.00249	CcSEcCtD
Mianserin—HRH1—tendon—systemic scleroderma	0.00144	0.0056	CbGeAlD
Mianserin—Syncope—Mycophenolic acid—systemic scleroderma	0.00144	0.00248	CcSEcCtD
Mianserin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00144	0.00248	CcSEcCtD
Mianserin—Fatigue—Captopril—systemic scleroderma	0.00144	0.00248	CcSEcCtD
Mianserin—Myalgia—Leflunomide—systemic scleroderma	0.00143	0.00247	CcSEcCtD
Mianserin—Arthralgia—Leflunomide—systemic scleroderma	0.00143	0.00247	CcSEcCtD
Mianserin—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00247	CcSEcCtD
Mianserin—Constipation—Captopril—systemic scleroderma	0.00143	0.00246	CcSEcCtD
Mianserin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00142	0.00246	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00142	0.00245	CcSEcCtD
Mianserin—ADRA2A—tendon—systemic scleroderma	0.00141	0.0055	CbGeAlD
Mianserin—Skin disorder—Azathioprine—systemic scleroderma	0.00141	0.00244	CcSEcCtD
Mianserin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00141	0.00243	CcSEcCtD
Mianserin—Dry mouth—Leflunomide—systemic scleroderma	0.0014	0.00242	CcSEcCtD
Mianserin—Convulsion—Mycophenolic acid—systemic scleroderma	0.00139	0.0024	CcSEcCtD
Mianserin—Rash—Pentoxifylline—systemic scleroderma	0.00139	0.00239	CcSEcCtD
Mianserin—Hypertension—Mycophenolic acid—systemic scleroderma	0.00139	0.00239	CcSEcCtD
Mianserin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00139	0.00239	CcSEcCtD
Mianserin—Headache—Pentoxifylline—systemic scleroderma	0.00138	0.00238	CcSEcCtD
Mianserin—Feeling abnormal—Captopril—systemic scleroderma	0.00137	0.00237	CcSEcCtD
Mianserin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00137	0.00236	CcSEcCtD
Mianserin—Myalgia—Mycophenolic acid—systemic scleroderma	0.00137	0.00236	CcSEcCtD
Mianserin—Asthenia—Mometasone—systemic scleroderma	0.00136	0.00235	CcSEcCtD
Mianserin—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00235	CcSEcCtD
Mianserin—Hypotension—Azathioprine—systemic scleroderma	0.00136	0.00234	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00136	0.00234	CcSEcCtD
Mianserin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00234	CcSEcCtD
Mianserin—Cardiac arrest—Prednisone—systemic scleroderma	0.00136	0.00234	CcSEcCtD
Mianserin—Tremor—Lisinopril—systemic scleroderma	0.00135	0.00234	CcSEcCtD
Mianserin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00233	CcSEcCtD
Mianserin—CYP1A2—lung—systemic scleroderma	0.00135	0.00525	CbGeAlD
Mianserin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00135	0.00232	CcSEcCtD
Mianserin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00134	0.00232	CcSEcCtD
Mianserin—Pruritus—Mometasone—systemic scleroderma	0.00134	0.00232	CcSEcCtD
Mianserin—Tachycardia—Leflunomide—systemic scleroderma	0.00134	0.00231	CcSEcCtD
Mianserin—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00134	0.00231	CcSEcCtD
Mianserin—Anaemia—Lisinopril—systemic scleroderma	0.00134	0.00231	CcSEcCtD
Mianserin—Skin disorder—Leflunomide—systemic scleroderma	0.00133	0.0023	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00133	0.00229	CcSEcCtD
Mianserin—Confusional state—Mycophenolic acid—systemic scleroderma	0.00132	0.00228	CcSEcCtD
Mianserin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00228	CcSEcCtD
Mianserin—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00226	CcSEcCtD
Mianserin—Oedema—Mycophenolic acid—systemic scleroderma	0.00131	0.00226	CcSEcCtD
Mianserin—Vertigo—Lisinopril—systemic scleroderma	0.0013	0.00224	CcSEcCtD
Mianserin—Syncope—Lisinopril—systemic scleroderma	0.0013	0.00224	CcSEcCtD
Mianserin—Leukopenia—Lisinopril—systemic scleroderma	0.00129	0.00223	CcSEcCtD
Mianserin—CYP2B6—lung—systemic scleroderma	0.00129	0.00503	CbGeAlD
Mianserin—Shock—Mycophenolic acid—systemic scleroderma	0.00129	0.00222	CcSEcCtD
Mianserin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00128	0.00222	CcSEcCtD
Mianserin—Hypotension—Leflunomide—systemic scleroderma	0.00128	0.00221	CcSEcCtD
Mianserin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00128	0.00221	CcSEcCtD
Mianserin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00128	0.00221	CcSEcCtD
Mianserin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00128	0.0022	CcSEcCtD
Mianserin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00127	0.0022	CcSEcCtD
Mianserin—Loss of consciousness—Lisinopril—systemic scleroderma	0.00127	0.00219	CcSEcCtD
Mianserin—HTR2A—digestive system—systemic scleroderma	0.00126	0.00492	CbGeAlD
Mianserin—HRH1—lung—systemic scleroderma	0.00126	0.00492	CbGeAlD
Mianserin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00126	0.00217	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00125	0.00216	CcSEcCtD
Mianserin—ADRA2A—lung—systemic scleroderma	0.00124	0.00483	CbGeAlD
Mianserin—Paraesthesia—Leflunomide—systemic scleroderma	0.00123	0.00213	CcSEcCtD
Mianserin—Arthralgia—Lisinopril—systemic scleroderma	0.00123	0.00212	CcSEcCtD
Mianserin—Myalgia—Lisinopril—systemic scleroderma	0.00123	0.00212	CcSEcCtD
Mianserin—Hypotension—Mycophenolic acid—systemic scleroderma	0.00122	0.00211	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00122	0.00211	CcSEcCtD
Mianserin—Lethargy—Methotrexate—systemic scleroderma	0.00122	0.0021	CcSEcCtD
Mianserin—Dry mouth—Lisinopril—systemic scleroderma	0.0012	0.00208	CcSEcCtD
Mianserin—HTR2A—tendon—systemic scleroderma	0.0012	0.00468	CbGeAlD
Mianserin—Feeling abnormal—Azathioprine—systemic scleroderma	0.0012	0.00207	CcSEcCtD
Mianserin—Rash—Mometasone—systemic scleroderma	0.0012	0.00206	CcSEcCtD
Mianserin—Asthenia—Captopril—systemic scleroderma	0.0012	0.00206	CcSEcCtD
Mianserin—Dermatitis—Mometasone—systemic scleroderma	0.0012	0.00206	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00119	0.00206	CcSEcCtD
Mianserin—Confusional state—Lisinopril—systemic scleroderma	0.00119	0.00205	CcSEcCtD
Mianserin—Headache—Mometasone—systemic scleroderma	0.00119	0.00205	CcSEcCtD
Mianserin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00205	CcSEcCtD
Mianserin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00119	0.00205	CcSEcCtD
Mianserin—Fatigue—Leflunomide—systemic scleroderma	0.00118	0.00204	CcSEcCtD
Mianserin—Oedema—Lisinopril—systemic scleroderma	0.00118	0.00204	CcSEcCtD
Mianserin—Pruritus—Captopril—systemic scleroderma	0.00118	0.00203	CcSEcCtD
Mianserin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00118	0.00203	CcSEcCtD
Mianserin—Constipation—Leflunomide—systemic scleroderma	0.00117	0.00203	CcSEcCtD
Mianserin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00202	CcSEcCtD
Mianserin—CYP3A4—digestive system—systemic scleroderma	0.00117	0.00455	CbGeAlD
Mianserin—Somnolence—Mycophenolic acid—systemic scleroderma	0.00116	0.00201	CcSEcCtD
Mianserin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00201	CcSEcCtD
Mianserin—Shock—Lisinopril—systemic scleroderma	0.00116	0.002	CcSEcCtD
Mianserin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00116	0.00199	CcSEcCtD
Mianserin—Neutropenia—Prednisone—systemic scleroderma	0.00115	0.00199	CcSEcCtD
Mianserin—Tachycardia—Lisinopril—systemic scleroderma	0.00115	0.00199	CcSEcCtD
Mianserin—CYP2D6—digestive system—systemic scleroderma	0.00115	0.00448	CbGeAlD
Mianserin—Skin disorder—Lisinopril—systemic scleroderma	0.00115	0.00198	CcSEcCtD
Mianserin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00196	CcSEcCtD
Mianserin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00196	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—systemic scleroderma	0.00114	0.00196	CcSEcCtD
Mianserin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00196	CcSEcCtD
Mianserin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00113	0.00195	CcSEcCtD
Mianserin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00113	0.00195	CcSEcCtD
Mianserin—Fatigue—Mycophenolic acid—systemic scleroderma	0.00113	0.00195	CcSEcCtD
Mianserin—Weight increased—Prednisone—systemic scleroderma	0.00112	0.00194	CcSEcCtD
Mianserin—Constipation—Mycophenolic acid—systemic scleroderma	0.00112	0.00193	CcSEcCtD
Mianserin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00192	CcSEcCtD
Mianserin—Hypotension—Lisinopril—systemic scleroderma	0.0011	0.0019	CcSEcCtD
Mianserin—Dizziness—Captopril—systemic scleroderma	0.0011	0.0019	CcSEcCtD
Mianserin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00189	CcSEcCtD
Mianserin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00189	CcSEcCtD
Mianserin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00108	0.00186	CcSEcCtD
Mianserin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00186	CcSEcCtD
Mianserin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00186	CcSEcCtD
Mianserin—Breast disorder—Methotrexate—systemic scleroderma	0.00108	0.00186	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00108	0.00186	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00185	CcSEcCtD
Mianserin—Paraesthesia—Lisinopril—systemic scleroderma	0.00106	0.00183	CcSEcCtD
Mianserin—HTR2A—lung—systemic scleroderma	0.00106	0.00411	CbGeAlD
Mianserin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00182	CcSEcCtD
Mianserin—Rash—Captopril—systemic scleroderma	0.00105	0.00181	CcSEcCtD
Mianserin—Dermatitis—Captopril—systemic scleroderma	0.00105	0.00181	CcSEcCtD
Mianserin—Somnolence—Lisinopril—systemic scleroderma	0.00105	0.00181	CcSEcCtD
Mianserin—Headache—Captopril—systemic scleroderma	0.00104	0.0018	CcSEcCtD
Mianserin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00104	0.0018	CcSEcCtD
Mianserin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00178	CcSEcCtD
Mianserin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00102	0.00176	CcSEcCtD
Mianserin—Fatigue—Lisinopril—systemic scleroderma	0.00102	0.00176	CcSEcCtD
Mianserin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00176	CcSEcCtD
Mianserin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00175	CcSEcCtD
Mianserin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00175	CcSEcCtD
Mianserin—Constipation—Lisinopril—systemic scleroderma	0.00101	0.00174	CcSEcCtD
Mianserin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00174	CcSEcCtD
Mianserin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.001	0.00173	CcSEcCtD
Mianserin—Bradycardia—Prednisone—systemic scleroderma	0.001	0.00173	CcSEcCtD
Mianserin—Asthenia—Leflunomide—systemic scleroderma	0.000985	0.0017	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—systemic scleroderma	0.000978	0.00169	CcSEcCtD
Mianserin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000973	0.00168	CcSEcCtD
Mianserin—Pruritus—Leflunomide—systemic scleroderma	0.000972	0.00168	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000969	0.00167	CcSEcCtD
Mianserin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00167	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—systemic scleroderma	0.000963	0.00166	CcSEcCtD
Mianserin—Dizziness—Azathioprine—systemic scleroderma	0.000962	0.00166	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000949	0.00164	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000942	0.00163	CcSEcCtD
Mianserin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00094	0.00162	CcSEcCtD
Mianserin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000929	0.0016	CcSEcCtD
Mianserin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000927	0.0016	CcSEcCtD
Mianserin—Eye disorder—Prednisone—systemic scleroderma	0.000922	0.00159	CcSEcCtD
Mianserin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000919	0.00159	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—systemic scleroderma	0.000918	0.00158	CcSEcCtD
Mianserin—Rash—Azathioprine—systemic scleroderma	0.000917	0.00158	CcSEcCtD
Mianserin—Dermatitis—Azathioprine—systemic scleroderma	0.000916	0.00158	CcSEcCtD
Mianserin—Headache—Azathioprine—systemic scleroderma	0.000911	0.00157	CcSEcCtD
Mianserin—Dizziness—Leflunomide—systemic scleroderma	0.000908	0.00157	CcSEcCtD
Mianserin—Angiopathy—Prednisone—systemic scleroderma	0.000895	0.00154	CcSEcCtD
Mianserin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00154	CcSEcCtD
Mianserin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000884	0.00153	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000869	0.0015	CcSEcCtD
Mianserin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000866	0.00149	CcSEcCtD
Mianserin—Rash—Leflunomide—systemic scleroderma	0.000866	0.00149	CcSEcCtD
Mianserin—Dermatitis—Leflunomide—systemic scleroderma	0.000865	0.00149	CcSEcCtD
Mianserin—Mental disorder—Prednisone—systemic scleroderma	0.000864	0.00149	CcSEcCtD
Mianserin—Headache—Leflunomide—systemic scleroderma	0.00086	0.00148	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000857	0.00148	CcSEcCtD
Mianserin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000852	0.00147	CcSEcCtD
Mianserin—Asthenia—Lisinopril—systemic scleroderma	0.000847	0.00146	CcSEcCtD
Mianserin—Pruritus—Lisinopril—systemic scleroderma	0.000835	0.00144	CcSEcCtD
Mianserin—Rash—Mycophenolic acid—systemic scleroderma	0.000826	0.00143	CcSEcCtD
Mianserin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000825	0.00142	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—systemic scleroderma	0.000825	0.00142	CcSEcCtD
Mianserin—Headache—Mycophenolic acid—systemic scleroderma	0.000821	0.00142	CcSEcCtD
Mianserin—Anaemia—Prednisone—systemic scleroderma	0.000794	0.00137	CcSEcCtD
Mianserin—Agitation—Prednisone—systemic scleroderma	0.000789	0.00136	CcSEcCtD
Mianserin—Dizziness—Lisinopril—systemic scleroderma	0.00078	0.00135	CcSEcCtD
Mianserin—Vertigo—Prednisone—systemic scleroderma	0.000772	0.00133	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—systemic scleroderma	0.000771	0.00133	CcSEcCtD
Mianserin—Syncope—Prednisone—systemic scleroderma	0.00077	0.00133	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—systemic scleroderma	0.000769	0.00133	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000765	0.00132	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—systemic scleroderma	0.000755	0.0013	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—systemic scleroderma	0.000748	0.00129	CcSEcCtD
Mianserin—Rash—Lisinopril—systemic scleroderma	0.000744	0.00128	CcSEcCtD
Mianserin—Convulsion—Prednisone—systemic scleroderma	0.000744	0.00128	CcSEcCtD
Mianserin—Dermatitis—Lisinopril—systemic scleroderma	0.000743	0.00128	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000743	0.00128	CcSEcCtD
Mianserin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000742	0.00128	CcSEcCtD
Mianserin—Hypertension—Prednisone—systemic scleroderma	0.000741	0.00128	CcSEcCtD
Mianserin—Headache—Lisinopril—systemic scleroderma	0.000739	0.00128	CcSEcCtD
Mianserin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000732	0.00126	CcSEcCtD
Mianserin—Arthralgia—Prednisone—systemic scleroderma	0.000731	0.00126	CcSEcCtD
Mianserin—Myalgia—Prednisone—systemic scleroderma	0.000731	0.00126	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000726	0.00125	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—systemic scleroderma	0.000722	0.00125	CcSEcCtD
Mianserin—Oedema—Prednisone—systemic scleroderma	0.000701	0.00121	CcSEcCtD
Mianserin—Shock—Prednisone—systemic scleroderma	0.00069	0.00119	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—systemic scleroderma	0.000687	0.00119	CcSEcCtD
Mianserin—Tachycardia—Prednisone—systemic scleroderma	0.000684	0.00118	CcSEcCtD
Mianserin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000684	0.00118	CcSEcCtD
Mianserin—Skin disorder—Prednisone—systemic scleroderma	0.000681	0.00117	CcSEcCtD
Mianserin—Anaemia—Methotrexate—systemic scleroderma	0.000663	0.00114	CcSEcCtD
Mianserin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000652	0.00112	CcSEcCtD
Mianserin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000651	0.00112	CcSEcCtD
Mianserin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000648	0.00112	CcSEcCtD
Mianserin—Vertigo—Methotrexate—systemic scleroderma	0.000645	0.00111	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—systemic scleroderma	0.000642	0.00111	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000639	0.0011	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—systemic scleroderma	0.000629	0.00109	CcSEcCtD
Mianserin—Convulsion—Methotrexate—systemic scleroderma	0.000622	0.00107	CcSEcCtD
Mianserin—Myalgia—Methotrexate—systemic scleroderma	0.000611	0.00105	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—systemic scleroderma	0.000611	0.00105	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000607	0.00105	CcSEcCtD
Mianserin—Fatigue—Prednisone—systemic scleroderma	0.000604	0.00104	CcSEcCtD
Mianserin—Constipation—Prednisone—systemic scleroderma	0.000599	0.00103	CcSEcCtD
Mianserin—Confusional state—Methotrexate—systemic scleroderma	0.000591	0.00102	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—systemic scleroderma	0.000578	0.000997	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000574	0.000991	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000574	0.00099	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—systemic scleroderma	0.000569	0.000982	CcSEcCtD
Mianserin—Hypotension—Methotrexate—systemic scleroderma	0.000547	0.000944	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000534	0.000921	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—systemic scleroderma	0.000526	0.000908	CcSEcCtD
Mianserin—Somnolence—Methotrexate—systemic scleroderma	0.000521	0.000898	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000506	0.000873	CcSEcCtD
Mianserin—Fatigue—Methotrexate—systemic scleroderma	0.000505	0.000871	CcSEcCtD
Mianserin—Asthenia—Prednisone—systemic scleroderma	0.000503	0.000868	CcSEcCtD
Mianserin—Pruritus—Prednisone—systemic scleroderma	0.000496	0.000856	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000483	0.000833	CcSEcCtD
Mianserin—Dizziness—Prednisone—systemic scleroderma	0.000464	0.0008	CcSEcCtD
Mianserin—Rash—Prednisone—systemic scleroderma	0.000442	0.000762	CcSEcCtD
Mianserin—Dermatitis—Prednisone—systemic scleroderma	0.000442	0.000762	CcSEcCtD
Mianserin—Headache—Prednisone—systemic scleroderma	0.000439	0.000758	CcSEcCtD
Mianserin—Asthenia—Methotrexate—systemic scleroderma	0.00042	0.000725	CcSEcCtD
Mianserin—Pruritus—Methotrexate—systemic scleroderma	0.000414	0.000715	CcSEcCtD
Mianserin—Dizziness—Methotrexate—systemic scleroderma	0.000387	0.000668	CcSEcCtD
Mianserin—Rash—Methotrexate—systemic scleroderma	0.000369	0.000637	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—systemic scleroderma	0.000369	0.000637	CcSEcCtD
Mianserin—Headache—Methotrexate—systemic scleroderma	0.000367	0.000633	CcSEcCtD
